Click Here to Register

This webinar will explore the latest evidence on managing residual cardiovascular risk supported by a case study and include practical tools and resources to optimise CVD risk factor management within primary healthcare. Discussion will include:   – Current guideline-based management strategies for CVD risk reduction, including BP, lipids, diabetes medicines, antiplatelets. – Lipid subfractions, such as Lp(a) and their use in clinical practice for risk identification and update on emerging treatments. – Key genetic determinants of CVD and how polygenic risk can be utilised to enhance traditional screening strategies. – Inflammatory, thrombotic and diabetes considerations for residual CVD risk. – A case study illustrating the practical application of approaches to managing residual risk in primary care. This webinar has been accredited with the RACGP for 1 hour. Activity number: 461157.